S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

TY - JOUR

T1 - S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

AU - Görög, A.

AU - Antiga, E.

AU - Caproni, M.

AU - Cianchini, G.

AU - De, D.

AU - Dmochowski, M.

AU - Dolinsek, J.

AU - Drenovska, K.

AU - Feliciani, C.

AU - Hervonen, K.

AU - Lakos Jukic, I.

AU - Kinyó, null

AU - Koltai, T.

AU - Korponay-Szabó, I.

AU - Marzano, A. V.

AU - Patsatsi, A.

AU - Rose, C.

AU - Salmi, T.

AU - Schmidt, E.

AU - Setterfield, J.

AU - Shahid, M.

AU - Sitaru, C.

AU - Uzun, S.

AU - Valitutti, F.

AU - Vassileva, S.

AU - Yayli, S.

AU - Sárdy, M.

N1 - Funding Information: The authors are grateful to Prof. Alexander Nast for review and contribution to the final manuscript. We are indebted to Gabriella N?meth for organizational and secretarial help. The EADV supported and funded the development of these guidelines. We thank the European Dermatology Forum for the careful review of these guidelines. The patients have given written informed consent to publication of their clinical photographs. Publisher Copyright: © 2021 European Academy of Dermatology and Venereology Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/6

Y1 - 2021/6

N2 - Introduction: Dermatitis herpetiformis (DH) is a chronic, pruritic, gluten-induced skin disorder characterized by subepidermal granular IgA deposition and a variable degree of enteropathy identical to that seen in coeliac disease. So far, there has been no European consensus about the management of DH. Methods: The guidelines were created by small subgroups of a guideline committee consisting of 26 specialists from various medical fields and one patients’ representative. The members of the committee then discussed the guidelines and voted for the final version at two consensus meetings. The guidelines were developed under the support of the European Academy of Dermatology and Venereology (EADV) and in collaboration with the European Dermatology Forum (EDF). Results: The guidelines summarize evidence-based and expert-based recommendations (S2 level) for the management of DH (see Appendix). Conclusion: These guidelines will improve the quality of management of DH and support dermatologists in their diagnostic and therapeutic decisions.

AB - Introduction: Dermatitis herpetiformis (DH) is a chronic, pruritic, gluten-induced skin disorder characterized by subepidermal granular IgA deposition and a variable degree of enteropathy identical to that seen in coeliac disease. So far, there has been no European consensus about the management of DH. Methods: The guidelines were created by small subgroups of a guideline committee consisting of 26 specialists from various medical fields and one patients’ representative. The members of the committee then discussed the guidelines and voted for the final version at two consensus meetings. The guidelines were developed under the support of the European Academy of Dermatology and Venereology (EADV) and in collaboration with the European Dermatology Forum (EDF). Results: The guidelines summarize evidence-based and expert-based recommendations (S2 level) for the management of DH (see Appendix). Conclusion: These guidelines will improve the quality of management of DH and support dermatologists in their diagnostic and therapeutic decisions.

UR - http://www.scopus.com/inward/record.url?scp=85106198556&partnerID=8YFLogxK

U2 - 10.1111/jdv.17183

DO - 10.1111/jdv.17183

M3 - Article

C2 - 34004067

AN - SCOPUS:85106198556

SN - 0926-9959

VL - 35

SP - 1251

EP - 1277

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 6

ER -